| 摘要 |
<p>The present invention discloses a new polypeptide- human ATP-dependent serine protease 52, the polynucleotide encoding it and a method producing the polypeptide by DNA recombinant technology. The present invention further discloses a method treating various disorders, e.g., malignant neoplasm, hematopathy, HIV infection and immunological disease and various inflammations etc. The present invention also discloses an antagonist of the polypeptide and its therapeutic action. The present invention further discloses the use of the polynucleotide encoding the new human ATP-dependent serine protease 52.</p> |
